Healthtech Startups

Qorvo develops radio frequency and power semiconductor components, including front-end modules, power amplifiers, filters, switches, GaN transistors, and power management ICs. Its products serve applications such as Wi-Fi, 5G, cellular, defense/aerospace, and cable/CATV infrastructure.

4 investors

Rapid Micro Biosystems manufactures automated laboratory testing systems and consumables for pharmaceutical and cell therapy manufacturers to conduct microbiological quality control testing, replacing manual methods with platform-based analysis.

4 investors

RapidPulse Medical is an investor relations page showcasing multiple healthcare-focused investment firms and incubators that back medical device and healthcare technology companies.

4 investors

Ready Set Food produces food products designed for early allergen introduction in infants, supporting medical guidance from pediatricians and national health associations. The product line targets parents introducing common food allergens to babies as early as 4 months of age to help reduce allergy risk.

4 investors

Recora builds technology for heart and lung health management and care navigation, designed to help people pursue preventive health goals and live longer, fuller lives.

4 investors

Red Arrow Therapeutics develops cancer therapies using a proprietary nanopolymer drug-delivery system for programmable encapsulation and release of biologics such as peptides, antibodies, and proteins. It aims to build a pipeline of polymer-drug conjugate cancer drugs with targeted tumor delivery and reduced off-tumor toxicity.

4 investors

Regeneron is a biotechnology company that develops medicines ranging from biologics to genetic medicines to treat serious diseases across areas such as metabolic disease, ophthalmology, and rare disease. The company focuses on research and development driven by human biology, with a clinical trial pipeline addressing conditions like generalized myasthenia gravis.

4 investors

REGENXBIO is a gene therapy company developing treatments for rare and retinal diseases using its NAV Technology Platform of viral vectors, which it also licenses to other pharmaceutical and biotech companies. It operates a late-stage clinical pipeline and manufactures its investigational gene therapies at its facility in Rockville, MD.

4 investors

Repair Biotechnologies develops the Cholesterol Degrading Platform, a therapeutic approach for treating conditions caused by localized accumulations of excess cholesterol. Its lead application aims to reduce atherosclerotic plaque in arteries to address cardiovascular diseases such as stroke and heart attack.

4 investors

Replay develops gene therapies for patients with rare genetic diseases. It operates in the biotechnology and gene therapy sector.

4 investors

Reshape provides an AI-driven operating system that automates microbiology data capture and analysis for research laboratories. The platform structures experimental results and surfaces insights to help lab teams accelerate research and product development.

4 investors

RethinkFirst provides behavioral health software and evidence-based tools, including autism (ASD) treatment training and special needs/behavior management solutions, serving K-12 education, employers, providers, and payors. Founded in 2007, the company applies data science and analytics to support value-based care for individuals with behavioral health challenges and their caregivers.

4 investors

Reverb Therapeutics develops immunotherapies built on its Amplify•R platform, which modulates the body's natural immune system using targeted molecules such as IL-15-directed compounds. Its pipeline addresses cancer, autoimmune disease, and cell therapy support, with lead candidate AMP01 advancing toward clinical trials.

4 investors

RevSpring provides patient and member engagement solutions for healthcare providers and payers, combining behavioral data, financial insights, and multi-channel (digital and print) communications to guide patients from provider search through final payment. Its platform uses proprietary healthcare data and AI to support scheduling, patient financial experience, and billing communications.

4 investors

Ride Health connects healthcare organizations with transportation services to ensure patients, particularly older adults and people with disabilities, can reliably access medical care. The platform manages dignified, accessible transportation to reduce missed appointments and improve health outcomes.

4 investors

Rinse combines technology and hospitality with science-based dental care to provide preventive oral health services through modern studio experiences. It aims to modernize dentistry by addressing fragmented industry practices and outdated approaches.

4 investors

Riva Health offers a program that measures and manages cardiovascular health using a smartphone. The product targets consumers seeking to monitor and manage their heart health.

4 investors

Roivant develops pharmaceutical medicines and medical technologies through a subsidiary model called "Vants," focused on accelerating the development and commercialization of treatments for dermatology and other therapeutic areas. The company operates as a biopharmaceutical holding with multiple focused companies advancing drug candidates through clinical trials and commercial launch.

4 investors

Rondo Therapeutics is an immuno-oncology biopharmaceutical company developing bispecific/multispecific antibody therapeutics designed for tumor-selective targeting to treat solid tumors while sparing healthy tissue. Its therapies aim to expand the therapeutic window for eradicating tumors.

4 investors

Roobrik provides science-based online surveys, financial-readiness assessments, and chat tools that help prospective senior living residents and their families evaluate their options while converting more website visitors into qualified leads for senior living providers. Its lead conversion and decision-support software is used by senior living communities across the full continuum of care.

4 investors

Rosy is a women's health technology platform that provides women with resources, community support, and research-backed solutions for sexual health concerns. The company serves women seeking education and care in sexual wellness.

4 investors

Route 92 Medical develops neurointervention catheter systems and devices aimed at improving outcomes for neurovascular patients, including stroke treatment. Its products are designed to navigate tortuous vascular anatomy and reach target locations for procedures such as aspiration.

4 investors

RQ Bio discovers and develops long-acting monoclonal antibodies (LAAbs) targeting seasonal influenza to provide protection against severe viral disease. It focuses on immunocompromised populations such as newborns, the elderly, and patients with weakened immunity who may not respond well to seasonal vaccines.

4 investors

Rythm offers monthly blood testing and biomarker tracking to help consumers monitor health metrics over time, providing actionable insights for optimization rather than one-time snapshots.

4 investors